Acadia Healthcare Company Inc Forecasted to Earn Q4 2018 Earnings of $0.32 Per Share (ACHC)

Share on StockTwits

Acadia Healthcare Company Inc (NASDAQ:ACHC) – Investment analysts at William Blair lowered their Q4 2018 earnings per share (EPS) estimates for shares of Acadia Healthcare in a research report issued on Tuesday, November 6th. William Blair analyst R. Daniels now anticipates that the company will earn $0.32 per share for the quarter, down from their previous forecast of $0.62. William Blair also issued estimates for Acadia Healthcare’s Q3 2019 earnings at $0.71 EPS.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Monday, November 5th. The company reported $0.55 earnings per share for the quarter, missing analysts’ consensus estimates of $0.64 by ($0.09). The business had revenue of $760.90 million during the quarter, compared to the consensus estimate of $760.46 million. Acadia Healthcare had a net margin of 7.43% and a return on equity of 7.71%. The firm’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same period last year, the business posted $0.58 EPS.

A number of other analysts have also recently issued reports on ACHC. ValuEngine upgraded shares of Acadia Healthcare from a “strong sell” rating to a “sell” rating in a research note on Thursday, July 26th. Zacks Investment Research upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and set a $48.00 target price for the company in a research note on Tuesday, July 24th. BidaskClub upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Wednesday, October 31st. Mizuho set a $37.00 target price on shares of Acadia Healthcare and gave the stock a “hold” rating in a research note on Tuesday, August 28th. Finally, BMO Capital Markets cut shares of Acadia Healthcare from an “outperform” rating to a “market perform” rating and set a $45.00 target price for the company. in a research note on Wednesday, August 1st. Eight investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Acadia Healthcare presently has a consensus rating of “Hold” and an average price target of $43.11.

Shares of ACHC opened at $42.50 on Thursday. Acadia Healthcare has a one year low of $26.92 and a one year high of $45.35. The stock has a market capitalization of $3.61 billion, a PE ratio of 17.19, a PEG ratio of 1.61 and a beta of 0.22. The company has a quick ratio of 1.24, a current ratio of 1.26 and a debt-to-equity ratio of 1.19.

In other Acadia Healthcare news, Director Reeve B. Waud sold 41,865 shares of Acadia Healthcare stock in a transaction dated Thursday, November 1st. The shares were sold at an average price of $45.00, for a total value of $1,883,925.00. Following the completion of the sale, the director now owns 14,213 shares in the company, valued at approximately $639,585. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 11.10% of the stock is owned by insiders.

Several institutional investors have recently made changes to their positions in the stock. Teacher Retirement System of Texas grew its holdings in shares of Acadia Healthcare by 8.0% during the 2nd quarter. Teacher Retirement System of Texas now owns 17,842 shares of the company’s stock valued at $730,000 after purchasing an additional 1,324 shares during the last quarter. People s United Financial Inc. grew its holdings in shares of Acadia Healthcare by 14.7% during the 2nd quarter. People s United Financial Inc. now owns 10,549 shares of the company’s stock valued at $432,000 after purchasing an additional 1,350 shares during the last quarter. Amalgamated Bank grew its holdings in shares of Acadia Healthcare by 9.7% during the 2nd quarter. Amalgamated Bank now owns 17,268 shares of the company’s stock valued at $706,000 after purchasing an additional 1,528 shares during the last quarter. Condor Capital Management grew its holdings in shares of Acadia Healthcare by 9.0% during the 3rd quarter. Condor Capital Management now owns 19,526 shares of the company’s stock valued at $687,000 after purchasing an additional 1,611 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. grew its holdings in shares of Acadia Healthcare by 10.2% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 18,111 shares of the company’s stock valued at $638,000 after purchasing an additional 1,672 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

Further Reading: Stock Symbols, CUSIP and Other Stock Identifiers

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply